Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 3Urinary Bladder Neoplasms 1Ureteral Neoplasms 1Pancreatic Neoplasms 1Neoplasms by Site 1Neoplasm Metastasis 1Liver Neoplasms 1Liver Diseases 1Hemangiosarcoma 1Digestive System Neoplasms 1Carcinoma, Transitional Cell 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1

Interventions

atezolizumab 2Sorafenib 2Bevacizumab 2titanium silicide 1ledipasvir, sofosbuvir drug combination 1halofantrine 1genexol-PM 1durvalumab 1avatrombopag 1aumolertinib 1Sunitinib 1Ramucirumab 1Neoadjuvant Therapy 1N-monoacetylcystine 1Leucovorin 1Injections 1Immunotherapy 1Formyltetrahydrofolates 1Everolimus 1Cisplatin 1Catheter Ablation 1Adjuvants, Pharmaceutic 1Acetylcysteine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Liver Diseases × genexol-PM × Clear all
NCT03008512 2021-02-04

A Phase II Study of Weekly Genexol-PM in Patients With Hepatocelluar Carcinoma After Failure of Sorafenib

Gachon University Gil Medical Center

Phase 2 Terminated
5 enrolled
Gastrointestinal

Digestive System Neoplasms, Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms, Neoplasms by Site

Data powered by HemOnc (CC BY 4.0) Colophon âš¡